A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0362 in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 08 Jun 2015
At a glance
- Drugs Insulin (Primary) ; Insulin (Primary) ; Insulin glargine
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- 01 Oct 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Jun 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 18 May 2012 New trial record